Daily Summary for 2026-10-21

daily

Video file (mp4)

Transcript

Introduction to the show: ident: Genomics Radio. Generated commentary on the latest computational biology and genomics papers.

Ines: It's the twenty-first of October, twenty twenty-six, and this is the day's research.

Marcus: 19 new papers came out today.

Ines: Hi, I'm Ines.

Marcus: And I'm Marcus, here with Yuki.

Ines: We'll take the day in one pass, then pull out the papers we're staying with.

Marcus: Start us off with Dynamic response phenotypes and model discrimination in systems and synthetic biology.

The summary: Ines: Welcome to the twenty first of October, twenty twenty six. Today we focus on better understanding calcium signaling dynamics in cell culture using data driven modeling because clearer pictures allow us to observe systems with greater detail.

Marcus: We are comparing two methods for system identification and parameter discovery for governing ordinary differential equations.

Yuki: Specifically the Constrained Regularized Least-Squares Method CRLSM and Physics Informed Neural Networks PINN.

Ines: This comparison is in the work titled Data driven multi agent modelling of calcium interactions in cell culture PINN vs Regularized Least-squares.

Marcus: What does this comparison mean for our understanding?

Yuki: It helps us characterize biological systems with greater detail by providing clearer pictures of these processes.

Ines: So the focus is on how we are trying to better understand calcium signaling dynamics in cell culture using data driven modeling.

Marcus: The methods being compared are CRLSM and PINN for discovering parameters in ordinary differential equations.

Yuki: The study uses these methods to see if one provides a clearer picture of the underlying system behavior.

Ines: We are comparing those two approaches in the paper Data driven multi agent modelling of calcium interactions in cell culture PINN vs Regularized Least-squares.

Marcus: Does this comparison illuminate how we observe and characterize biological systems with greater detail?

Yuki: Yes getting a clearer picture of these processes allows us to see biological systems with greater detail.

Ines: How does digital monitoring inform clinical practice?

Marcus: Establishing the Minimal Clinically Important Difference for Smartphone-Derived Gait Measures in Multiple Sclerosis sets concrete thresholds.

Yuki: This relates to data-driven discovery, comparing physics-informed neural networks and regularized least squares methods.

Ines: That comparison identifies parameters governing calcium interactions in cell culture.

Marcus: The most significant finding concerns how receptive field shapes in the primary visual cortex might vary.

Yuki: Do the receptive fields span variability over the degree of elongation?

Ines: This suggests biological receptive field shapes should span degrees of freedom from affine image transformations.

Marcus: It supports affine covariance across a population.

Yuki: This builds on Tony Lindeberg's proposal for simple cells under various transformations.

Ines: His work in AKMPC suggested receptive fields should be covariant under uniform spatial scaling and temporal scaling.

Marcus: This covariance concept is examined in orientation selectivity properties for integrated affine quasi quadrature models of complex cells.

Yuki: That shows assuming spatial receptive fields are covariant implies they must span variability over the degree of elongation.

Ines: PINNs failed to match CRLSM performance today.

Marcus: They did not provide fair parameter estimation under their setup.

Yuki: This suggests room for improvement through tuning and uncertainty quantification.

Ines: PINNs are promising but need more careful tuning for future research.

Marcus: Agreed, uncertainty quantification is key now to see real gains.

Yuki: Data-driven multi-agent modelling of calcium interactions in cell culture: PINN vs Regularized Least-squares is worth hearing because it compares these methods for modeling calcium delivery.

Ines: That comparison helps us understand the trade-offs clearly.

Marcus: It allows better observation and characterization of processes like calcium signaling in cell culture.

Yuki: Data-driven discovery of dynamics in biological systems is valuable for observing such complex processes.

Lucky paper: 2512.24945: Ines: We’re moving into a paper that really reorients systems biology by focusing on transient responses rather than just steady states in the title Dynamic response phenotypes and model discrimination in systems and synthetic biology.

Marcus: The authors argue that biological function is encoded in the structure of these transient responses, like overshoots or adaptation kinetics.

Yuki: They use control theory to define systems with inputs and outputs so they can test if certain network structures can generate specific behaviors.

Ines: This paper suggests that dynamic phenotypes are a source of structural information that constrains underlying network architectures independently of the specific kinetic parameter values.

Marcus: The authors identified incoherent feedforward motifs as a central theme because they generate non-monotonic and adaptive responses.

Yuki: They contrast these incoherent feedforward motifs with coherent ones to help distinguish whether a system is exhibiting monotonic or non-monotonic behavior.

Ines: A key signature they propose is the adaptation triad, which involves two incoherent feedforwards and one nonlinear integral feedback loop.

Marcus: That sounds like a lot of structural constraints for the network.

Yuki: The paper also highlights fold-change detection as a signature of scale invariance, which means system responses become independent of measurement units.

Ines: That scale invariance is tested against biological measurements in simple cells in the primary visual cortex.

Marcus: It suggests that biological receptive field shapes should span the degrees of freedom in affine image transformations.

Yuki: This implies that spatial receptive fields must exhibit variability over the degree of elongation, which is supported by theoretical modeling too.

Ines: The paper also uses this concept to show that orientation selectivity becomes narrower when the scale parameter ratio increases in affine Gaussian derivative models.

Marcus: That connects the geometric transformation idea to how simple cells respond to changing spatial scales.

Yuki: Beyond those visual applications, they look at cooperation in structured populations where migration patterns influence whether cooperators can escape defector-rich areas.

Ines: That links the variability of payoffs in social interactions to how selection can favor cooperation even when the population is well-mixed.

Marcus: The paper does acknowledge a limitation regarding retroactivity, saying that upstream modules might qualitatively alter the transient features being analyzed.

Yuki: That's a fair caveat because biological systems are rarely purely feedforward and have complex interconnection logic.

Ines: Overall, the core contribution is using control theory concepts to perform model class tests by asking which qualitative behaviors a model class can or cannot generate.

Marcus: So instead of trying to find exact parameters, we test what kind of dynamic behavior a network is capable of producing.

Yuki: Exactly, and it shifts the focus from asymptotic equilibrium toward input-driven dynamics as the primary source for structural information.

Lucky paper: 2606.22448: Ines: We are moving on to a paper that deals with the kinetics of template directed multistate copolymerization, which is titled Kinetics of template-directed multistate copolymerization by Pierre Gaspard.

Marcus: This study shows how the kinetic equations for these processes can be exactly solved for the mean growth velocity, sequence probabilities of the grown copy, and local probabilities and fractions of monomeric units in the copy.

Yuki: The process is described by a Markov jump process where system states include the catalyst, template, and its copy.

Ines: They use a matrix factorization ansatz to solve these kinetic equations using an iterated matrix function system that runs backward along the template.

Marcus: This backward iteration combined with a forward iteration leads to an exact solution for the mean growth velocity and the probabilities of the copy sequences.

Yuki: They found that if the template is periodic, there are two generic regimes: a stationary regime where mean length converges toward a finite and stationary value, and a steady growth regime where the mean length increases linearly in time with v > zero.

Ines: If the template is disordered, an intermediate regime exists where the mean length manifests sublinear growth in time like h lit about t gamma with an exponent gamma between zero and one.

Marcus: The numerical validation compared the IMFS method against Gillespie’s algorithm for the corresponding stochastic process.

Yuki: The IMFS method is more than a million times faster than the numerical simulation method based on Gillespie’s algorithm, while always giving the exact asymptotic solution of the problem.

Ines: That comparison confirms that both methods provide exact values for the mean growth velocity and the local probabilities of monomeric units for the copy grown along a given template.

Marcus: The paper concludes that if attachment rates are too small with respect to detachment rates, the growth of the copy is stalled.

Yuki: They also noted that in Appendix B, if a copolymer chain grows along a disordered template, its mean length may increase sublinearly in time as h lit about t gamma with an exponent zero and gamma less than one.

Ines: The IMFS method is extremely powerful because it provides the exact asymptotic solution of the kinetic equations ruling the stochastic process.

Marcus: This IMFS method is applied to a numerical example and its results are compared to those obtained by numerical simulations with Gillespie’s algorithm.

Yuki: In Appendix C, they calculate the mean local dwell time tau l of the catalyst of the template by averaging over a large enough statistical ensemble of N stat random copies generated with Gillespie’s algorithm.

Ines: The iterative method with N loop = one hundred two is four times ten to six times faster than the numerical simulation using Gillespie’s algorithm with N stat = ten to nine.

Marcus: The exact asymptotic solution of the kinetic equations is provided by the backward and forward iterations in Appendix D.

Yuki: The exact solution for the mean growth velocity is given by v = P L sum l=one L t V l-one times l-one.

Ines: So this paper shows how kinetic equations can be exactly solved for growth characteristics in template directed multistate copolymerization.

Lucky paper: 2601.13714: Ines: We're moving on to a new topic today, looking at how we can use dynamic modeling to inform public health policy in Korea.

Marcus: We're going to discuss the Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile.

Yuki: This paper looks at prioritizing adults aged forty to fifty-nine years for vaccination because that seems like the most balanced approach given the shifting cohort demographics.

Ines: So it's about how to manage limited resources when a disease risk changes with age, specifically looking at the Cost-Effectiveness of Adult Hepatitis A Vaccination Strategies in Korea Under an Aging Susceptibility Profile.

Marcus: The study developed an age-structured transmission model calibrated to Korean data and ran a simulation for cost-effectiveness across two perspectives.

Yuki: They stratified the population into eight ten-year age groups and tested three vaccination scenarios: targeting twenty to thirty-nine years, targeting forty to fifty-nine years with antibody testing, and targeting everyone from twenty to fifty-nine with testing applied only to those aged over forty.

Ines: The key finding is that scenario S2, which targets adults aged forty to fifty-nine years with pre-vaccination antibody testing, yielded the most favorable and robust cost-effectiveness profile under both healthcare and societal perspectives.

Marcus: In terms of DALYs averted, scenario S3, vaccinating everyone from twenty to fifty-nine years with antibody testing for those over forty achieved the largest reduction in DALYs but required substantially higher incremental costs compared to S2.

Yuki: The optimal control strategies showed how vaccination effort would be preferentially allocated across age groups under each strategy, and specifically in scenario S3, the doses were distributed almost evenly across adults from their 20s through the 50s from two thousand twenty-five through the early 2040s.

Ines: The incremental cost effectiveness ratio ICER was defined as Cost i minus Cost base divided by DALY base minus DALY i, and S2 consistently emerged as the most efficient strategy with an ICER of USD fifty-two thousand one hundred sixty-six per DALY averted in the healthcare system perspective.

Marcus: That means S2 achieved a sizable reduction of seven thousand four hundred fifty-eight DALYs averted with only a moderate increase in costs from that perspective.

Yuki: The societal perspective showed that the incremental costs for both S2 and S3 are generally higher than those in the healthcare system, which accounts for things like productivity losses.

Ines: The authors note that prioritizing middle-aged adults provides the clearest value for money under realistic capacity and budget constraints in Korea’s evolving epidemiological context.

Marcus: They also mentioned some limitations, specifically that long-term projections depend on assumptions about future transmission intensity captured through the force of infection, and they didn't explicitly stratify high-risk subgroups with markedly elevated fatality.

Yuki: These results underscore the importance of dynamic, context-specific economic evaluations for adult immunization policy in aging populations.

Lucky paper: 2606.28449: Ines: We're looking at a paper today titled Establishing the Minimal Clinically Important Difference for Smartphone-Derived Gait Measures in Multiple Sclerosis.

Marcus: This study is all about setting robust and clinically meaningful MCIDs for smartphone derived digital gait measures in progressive MS patients.

Yuki: The core idea is that we need established minimal clinically important differences to tell daily variability apart from actual disease progression in longitudinal data.

Ines: Gait impairments are a major part of MS, affecting quality of life and independence, so this data collection method is promising because it uses smartphone inertial measurement units or IMUs for continuous gait monitoring.

Marcus: They used a phase 3b study called CONSONANCE over two years where participants did daily two minute walk tests.

Yuki: The researchers looked at several anchors during study visits, including performance based measures like the timed twenty-five-foot walk and clinician rated scores like EDSS and its Ambulation Score subcomponent.

Ines: They also included patient reported outcomes such as the twelve item multiple sclerosis walking scale MSWS-twelve and patient impression of severity for lower limbs PSI Lower Limbs.

Marcus: Longitudinal change was determined by median values aggregated over four week windows at baseline and Week ninety-six for the digital gait measures.

Yuki: For each anchor, participants were split into "worsened" or "stable" cohorts based on predefined ninety-six week change thresholds.

Ines: The paper Establishing the Minimal Clinically Important Difference for Smartphone-Derived Gait Measures in Multiple Sclerosis found that overall change in patient perceived walking impairment as measured by MSWS-twelve had the strongest correlations with digital gait measures.

Marcus: They saw at least one correlation with rho greater than or equal to zero point three for multiple digital gait measures.

Yuki: The highest absolute correlation was between Step Velocity Scaled to Walking Time and MSWS-twelve which was rho equals minus zero point thirty-three.

Ines: The triangulation of median changes from baseline across the different anchors yielded specific MCID estimates for MS disease progression.

Marcus: For example, the proposed MCID estimates are step velocity of minus zero point sixteen meters per second, and total distance walked of minus twenty-four meters.

Yuki: These proposed MCID estimates are consistent with prior research and they were derived using an anchor based method which they say is generally more accepted than distribution based methods.

Ines: They found that the digital measures are highly relevant to patients because patients reported symptoms directly related to gait performance and daily activities.

Marcus: The study acknowledges limitations like sample size constraints and the need for further validation in larger, independent MS cohorts.

Yuki: These MCID estimates provide a conservative yet reliable framework for interpreting gait progression in people with multiple sclerosis.

Ines: These thresholds have important implications for clinical trials and for real world monitoring by offering objective insights into gait changes.

Lucky paper: 2607.17405: Ines: Welcome back to Genomics Radio. We are looking at a paper today called Evaluating Conformal Reliability of Pathway-Level Transcriptomic Signatures Under Cross-Cohort Shift in Sepsis Mortality Prediction, and we're going to talk about how data representation matters when deploying these models.

Marcus: This study presents a framework for evaluating transcriptomic sepsis mortality prediction under realistic cross-cohort deployment by comparing genelevel, pathwaylevel, and hybrid molecular representations.

Yuki: It works by taking four publicly available whole-blood transcriptomic cohorts with nine hundred thirty-six patients and two hundred forty-eight mortality events.

Ines: They harmonize this data into a shared feature space containing seven thousand six hundred sixty genes and three complementary representations: gene-level expression, Hallmark pathway activity scores, and a hybrid gene-and-pathway representation.

Marcus: Then they assess each representation using leave-one-cohort-out validation with logistic regression, random forest, XGBoost, and LightGBM.

Yuki: They systematically compared these three molecular representations to see which performs best under the shift.

Ines: Gene-level and hybrid representations generally achieved the strongest discriminative performance in this paper.

Marcus: But pathway-level representations showed greater robustness across model families in terms of conformal prediction and calibration analysis, according to the study.

Yuki: The researchers introduced a Pathway Stability Index or PSI to quantify these stable, transferable signals.

Ines: PSI measures directional reproducibility and resampling analyses to separate biological signals that generalize from independent cohorts from associations unique to one dataset.

Marcus: High-PSI pathways had considerably greater external reproducibility compared to low-PSI pathways in this work.

Yuki: This connects to the biological interpretation, where highly stable transcriptomic features ranked highest in Gene Ontology and KEGG enrichment analysis.

Ines: These stable features corresponded most highly to immune and host-defense processes when looking at PSI ranked genes.

Marcus: The central recommendation is that maximizing AUROC or AUPRC alone is not enough when you are developing models intended for deployment across independent clinical settings.

Yuki: This emphasizes that representation choice influences not just predictive performance but also the reliability and transferability of these transcriptomic prognostic models, according to Evaluating Conformal Reliability of Pathway-Level Transcriptomic Signatures Under Cross-Cohort Shift in Sepsis Mortality Prediction.

Ines: The limitation mentioned is that conformal guarantees decrease as the extent of distribution shift increases, and more validation is needed for larger datasets.

Marcus: It shows that maximizing AUROC or AUPRC alone is insufficient when you are developing models intended for deployment across independent clinical settings in this paper.

More episodes

← Home